Open AccessSociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis
Author(s) -
Manuela Savino,
Anna Casula,
Shalini Santhakumaran,
David Pitcher,
Esther Wong,
Winnie Magadi,
Katharine Evans,
Fran Benoy-Deeney,
James M. Griffin,
Lucy Plumb,
Retha Steenkamp,
Dorothea Nitsch,
James Mu
Publication year - 2020
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0241263
Subject(s) - medicine , cohort , covid-19 , population , retrospective cohort study , cohort study , young adult , demography , disease , environmental health , infectious disease (medical specialty) , sociology
Kidney disease is a recognised risk factor for poor COVID-19 outcomes. Up to 30 June 2020, the UK Renal Registry (UKRR) collected data for 2,385 in-centre haemodialysis (ICHD) patients with COVID-19 in England and Wales. Overall unadjusted survival at 1 week after date of positive COVID-19 test was 87.5% (95% CI 86.1–88.8%); mortality increased with age, treatment vintage and there was borderline evidence of Asian ethnicity (HR 1.16, 95% CI 0.94–1.44) being associated with higher mortality. Compared to the general population, the relative risk of mortality for ICHD patients with COVID-19 was 45.4 and highest in younger adults. This retrospective cohort study based on UKRR data supports efforts to protect this vulnerable patient group.